BRIEF-EMA Says Prac Started Review Of Medicines Containing Hydroxyprogesterone

EMA:

* SAYS PRAC STARTED A REVIEW OF MEDICINES CONTAINING HYDROXYPROGESTERONE FOLLOWING CONCERNS ABOUT SAFETY AND EFFECTIVENESS OF THESE MEDICINES.

* PRAC STARTED REVIEW DUE CONCERNS FROM STUDY1 SUGGESTING PEOPLE EXPOSED TO HYDROXYPROGESTERONE CAPROATE IN WOMB MAY HAVE INCREASED RISK OF CANCER Source text for Eikon: Further company coverage: [ ]